A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first ...

The U.S. Food and Drug Administration has approved the marketing of a new tool that can test a person’s blood to diagnose ...

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

However, that could all change thanks to a new blood test called Lumipulse. On May 16, the U.S. Food & Drug Administration (FDA) approved the first-ever Alzheimer’s blood test. Lumipulse is the ...

The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith said that makes it the first and only test with that advantage.

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...

The Lumipulse blood plasma test detects a disease hallmark, amyloid plaques, which form in the brains of Alzheimer's patients. This approval marks a milestone for patients, their families and ...

In a Friday press release, the agency announced its approval of the first in-vitro diagnostic device, Lumipulse. The method is intended for early Alzheimer’s detection in adult patients over the ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and beta-amyloid 1-42 in plasma.

The Lumipulse test takes a simple blood draw. “Today’s clearance is an important step for Alzheimer’s disease diagnosis, making it easier and potentially more accessible for U.S. patients ...

"We designed our Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ... for Fujirebio's test comes years after other blood tests for Alzheimer's have already begun sales, without this kind of approval ...